C
NUVB icon

Covestor’s Nuvation Bio NUVB Stock Holding History

Covestor’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1K Buy
102
+73
+252% +$357 ﹤0.01% 2255
2026
Q1 		$0 Sell
29
-5
-15% -$28 ﹤0.01% 2615
2025
Q4 		$0 Hold
34
– – ﹤0.01% 2590
2025
Q3 		$0 Hold
34
– – ﹤0.01% 2604
2025
Q2 		$0 Sell
34
-3
-8% -$6 ﹤0.01% 2575
2025
Q1 		$0 Buy
37
+1
+3% +$2 ﹤0.01% 2568
2024
Q4 		$0 Buy
36
+2
+6% +$5 ﹤0.01% 2575
2024
Q3 		$0 Sell
34
-2
-6% -$6 ﹤0.01% 2576
2024
Q2 		$0 Sell
36
-348
-91% -$1.06K ﹤0.01% 2587
2024
Q1 		$1K Buy
384
+118
+44% +$227 ﹤0.01% 2047
2023
Q4 		$0 Buy
266
+222
+505% +$286 ﹤0.01% 2523
2023
Q3 		$0 Sell
44
-6
-12% -$10 ﹤0.01% 2511
2023
Q2 		$0 Sell
50
-1
-2% -$2 ﹤0.01% 2477
2023
Q1 		$0 Hold
51
– – ﹤0.01% 2399
2022
Q4 		$0 Buy
51
+22
+76% +$45 ﹤0.01% 2425
2022
Q3 		$0 Sell
29
-6
-17% -$17 ﹤0.01% 2392
2022
Q2 		$0 Sell
35
-9
-20% -$39 ﹤0.01% 2209
2022
Q1 		$0 Sell
44
-10
-19% -$56 ﹤0.01% 2323
2021
Q4 		$0 Buy
+54
New +$496 ﹤0.01% 2232

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Covestor's NUVB Position: Q2 2026 in Review

Covestor increased its Nuvation Bio (NUVB) stake by 252% in Q2 2026, buying an estimated $357 and bringing the position to 102 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #2255.

Covestor first reported a position in NUVB in Q4 2021 and has held it in 19 quarters since. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Covestor held 102 shares of Nuvation Bio worth $1K as of Q2 2026.
  • Covestor bought 73 Nuvation Bio shares in Q2 2026, an estimated $357.
  • Nuvation Bio made up ﹤0.01% of Covestor's portfolio in Q2 2026, its #2255 holding.
  • Covestor first reported a position in Nuvation Bio in Q4 2021 and has held it in 19 quarters since.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.